Are TRAX insiders buying or selling?

In the last 90 days, First (TRAX) had 2 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own TRAX?

See every hedge fund and asset manager holding First (TRAX).

How much of TRAX trades in dark pools?

Track First (TRAX) dark pool activity and off-exchange block trades.

First (TRAX) — 40.4% Short — Squeeze Watch

$17.18

+0.42 (+2.51%)

Weekly Expected Move ±19.1%

$10 $14 $17 $20 $23

NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $599.5M mcap · 31M float · 1.24% daily turnover · Short 41% of daily vol

Smart Money Score

Watch 25

Insider—

Congress—

ETF Holdings—

Key Statistics

Market Cap$599.5M

52W Range14.79-26.8

Volume308,932

Avg Volume383,950

Beta0.00

Dividend—

Analyst Ratings

No analyst coverage

Company Info

CEODaniel R. Faga

Employees104

SectorHealthcare

IndustryBiotechnology

IPO Date2026-04-20

Websitefirsttracksbio.com

10770 Wateridge Circle
San Diego, CA 92121
US

858 362 6295

About First Tracks Biotherapeutics Inc

First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.

Latest News